8-K
filed December 7, 2022, 6:59 PM ET
ticker CERO
CIK 0001870404
other material
confidence high
sentiment neutral
materiality 0.75
Phoenix Biotech Acquisition Corp. and Intrinsic Medicine mutually terminate business combination agreement
CERO THERAPEUTICS HOLDINGS, INC.
- Business combination agreement terminated on December 6, 2022 due to current market conditions.
- No termination fee or other payment due from any party as a result of the termination.
- Sponsor support agreement and intrinsic support agreements automatically terminated.
- PBAX CEO Chris Ehrlich expressed continued optimism about Intrinsic's platform.
Key facts
Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CERO THERAPEUTICS HOLDINGS, INC. terminated Sponsor Support Agreement with Phoenix Biotech Sponsor, LLC (effective 2022-12-06).
- Action
- termination
- Agreement
- asset purchase
- Counterparty
- Phoenix Biotech Sponsor, LLC
- Effective
- 2022-12-06
Exact text from the filing
The Sponsor Support Agreement, dated as of October 30, 2022 (the “ Sponsor Support Agreement ”), by and among the Company, Intrinsic, Phoenix Biotech Sponsor, LLC, a Delaware limited liability company, and each of the Company’s officers and directors, automatically terminated in accordance with its terms upon the termination of the Business Combination Agreement.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CERO THERAPEUTICS HOLDINGS, INC. terminated Business Combination Agreement with Intrinsic Medicine, Inc. (effective 2022-12-06).
- Action
- termination
- Agreement
- merger
- Counterparty
- Intrinsic Medicine, Inc.
- Effective
- 2022-12-06
Exact text from the filing
On December 6, 2022 (the “ Termination Date ”), the Company and Intrinsic entered into a Termination Agreement (the “ Termination Agreement ”), a copy of which is filed as Exhibit 2.1 hereto, which among other things provides for the mutual termination of the Business Combination Agreement
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CERO THERAPEUTICS HOLDINGS, INC. terminated Intrinsic Support Agreements with certain Intrinsic stockholders (effective 2022-12-06).
- Action
- termination
- Agreement
- asset purchase
- Counterparty
- certain Intrinsic stockholders
- Effective
- 2022-12-06
Exact text from the filing
The support agreements, dated as of October 30, 2022 (the “ Intrinsic Support Agreements ”), by and among the Company, Intrinsic and certain Intrinsic stockholders, automatically terminated in accordance with their terms upon the termination of the Business Combination Agreement.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.